• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

MDT buying CNMD













Those rumors are from 2020. leave it alone…never going to happen. Why would MDT buy a shit company that produces shit products?
…….
oh wait……MDT does that all the time. The board outsmarts themselves buying high and selling low.
 




Those rumors are from 2020. leave it alone…never going to happen. Why would MDT buy a shit company that produces shit products?
…….
oh wait……MDT does that all the time. The board outsmarts themselves buying high and selling low.

That last statement is on point. Too many MBA (especially Harvard and Jack Welsh) graduates that only understand finance engineering and not actual healthcare nuances are ruining the company.
With the depressed stock price, MDT can not afford additional acquisition. Market analysts are changing ratings to hold/sell even with the increased dividend payments. What does that signal? Stock price is overvalued.